Responsibility for implementation
The Board reviews and updates risks on a regular basis, maintains a risk register and addresses each potential risk in terms of likelihood and impact on the business.
We have identified six areas of potential risk: product development; operational; clinical and regulatory; finance and IT; HR; and commercial. The Board believes the following risks are the most significant for the Company, however, they may not necessarily comprise all the associated or potential risks attached to the Company. Alongside risks associated with changes in the market or economic conditions, the political landscape, legal, regulatory or tax implications. There may also be risks that the Directors are currently unaware of but that could have a significant effect on the Company’s ability to carry out its business. A list of the principal risks and mitigating factors facing the Group at this time are listed below, in no particular order.